Table 3 Characteristics of the included studies
Author | Study design | PROM measurement | Period of enrollment | Mean age (SD) | Gender | Participation in the study by eligible individuals | Proportion of patients that completed PROM | Country |
|---|---|---|---|---|---|---|---|---|
Delgado, 2015 | Multicenter Observational Prospective | At 6, 12, 36, 60, and 120 months after HT | December 2010 and December 2011 | 56.4 (11.4) | 77.9% male 22.1% female | 331 of 350 (94.57%) | 86.6% (303 of 350 HT patients) | Spain |
Farmer, 2013* | Multicenter Observational Prospective | At enrollment before HT and every 6 months during follow-up. The average follow-up per patient was 2.5 years | July 1, 1990 to June 30, 1999 | 54 (–) | 79% male 21% female | 597 of 885 (67%) | 93.0% (555 of 597 HT patients) | USA |
Harper, 1998 | Observational Prospective | At enrollment before HT | From November 1989 to June 1994 | 53.16 (11.19) | 86% male 14% female | 90 of 136 (66%) | 100% (90 of 90 HT patients) | USA |
O’Brien, 1987 | Observational Prospective at 2 medical centers | Before HT, once patients where accepted for HT at 3 months intervals After HT at 3 months intervals during 4.5 years | From April 1982 to 30 June 1985 | 42.8 (–) | 92.8% male 7.2% female | 73 of 221 (33%) | 100% (73 of 73 HT patients) | UK |
White-Williams, 2013* | Retrospective analysis of a prospective longitudinal study at 4 medical centers* | At 5 and 10 years after HT | July 1, 1990 to June 30, 1999 | 53.8 (–) | 78% male 22% female | 597 of 884 (68%) | 39% (216 of 555 HT patients) | USA |